NCT06370481 HIV, Equity, and Addiction Training (HEAT) Program
| NCT ID | NCT06370481 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | Substance Use Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-01-29 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-01-29 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project is a pilot study to determine the feasibility and acceptability of a telemedicine intervention for substance use disorder service delivery in diverse people living with HIV in Alabama.
Eligibility Criteria
Inclusion Criteria: * Receiving services at HIV clinics in Alabama * Reported opioid and/or stimulant misuse * 18 years of age or older Exclusion Criteria: * Receipt of SUD clinical care other than through HIV provider/clinic in the last 3 months * Inability to engage in interviews independently without support (e.g., cognitive impairment) * Currently psychotic * Actively suicidal: presents with a suicide attempt or suicidal ideation
Contact & Investigator
Ellen F Eaton, MD, MSPH
PRINCIPAL INVESTIGATOR
University of Alabama at Birmingham
Frequently Asked Questions
Who can join the NCT06370481 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Substance Use Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06370481 currently recruiting?
Yes, NCT06370481 is actively recruiting participants. Contact the research team at eeaton@uabmc.edu for enrollment information.
Where is the NCT06370481 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT06370481 clinical trial?
NCT06370481 is sponsored by University of Alabama at Birmingham. The principal investigator is Ellen F Eaton, MD, MSPH at University of Alabama at Birmingham. The trial plans to enroll 30 participants.